FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,198,000 | -68.4% | 242,000 | -29.2% | 0.23% | -75.7% |
| Q4 2016 | $3,796,000 | +19.9% | 342,000 | 0.0% | 0.96% | +86.2% |
| Q3 2016 | $3,167,000 | +45.8% | 342,000 | 0.0% | 0.52% | -8.5% |
| Q2 2016 | $2,172,000 | -2.6% | 342,000 | 0.0% | 0.56% | +16.8% |
| Q1 2016 | $2,230,000 | -19.6% | 342,000 | 0.0% | 0.48% | +19.0% |
| Q4 2015 | $2,774,000 | -0.4% | 342,000 | -10.0% | 0.41% | +14.4% |
| Q3 2015 | $2,785,000 | -28.5% | 380,000 | 0.0% | 0.36% | -7.1% |
| Q2 2015 | $3,895,000 | +110.5% | 380,000 | +90.0% | 0.38% | +97.9% |
| Q1 2015 | $1,850,000 | – | 200,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |